Aimil Pharmaceuticals(India) Profile
Key Indicators
- Authorised Capital ₹ 14.50 Cr
as on 28-09-2024
- Paid Up Capital ₹ 11.71 Cr
as on 28-09-2024
- Company Age 40 Year, 18 Days
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 102.35 Cr
as on 28-09-2024
- Satisfied Charges ₹ 16.00 Cr
as on 28-09-2024
- Revenue 7.39%
(FY 2023)
- Profit 41.07%
(FY 2023)
- Ebitda 20.12%
(FY 2023)
- Net Worth 11.95%
(FY 2023)
- Total Assets 26.49%
(FY 2023)
About Aimil Pharmaceuticals(India)
The Corporate was formerly known as Aimil Pharmaceuticals India Private Limited. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 14.50 Cr and a paid-up capital of Rs 11.71 Cr.
The company currently has active open charges totaling ₹102.35 Cr. The company has closed loans amounting to ₹16.00 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Aimil Pharmaceuticals(India) Limited India are Ram Sharma as CFO and Gaurav Agarwal as Company Secretary. Pankaj Marwaha, Kanwal Sharma, Manjula Sharma, and Two other members serve as directors at the Company.
- CIN/LLPIN
U24231DL1984PLC019461
- Company No.
019461
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
30 Nov 1984
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Central Delhi, Delhi, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Aimil Pharmaceuticals(India) Limited offer?
Aimil Pharmaceuticals(India) Limited offers a wide range of products and services, including Brain & Nervous System Drugs, Antidepressant & Anti Anxiety Medicines, Cardiovascular Drugs & Medication, Cardiac Drugs, Pain Relief Drugs & Pharmaceuticals, Arthritic Drugs, Infusion Syringes & Supplies, Vials and Ampoules, Pain Killers, TB, Tumor & Cancer Drugs.
Who are the key members and board of directors at Aimil Pharmaceuticals(India)?
Executive Team (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kanwal Sharma  | Managing Director | 30-Nov-1984 | Current |
| Ram Sharma | CFO | 27-Sep-2016 | Current |
| Gaurav Agarwal | Company Secretary | 01-Jul-2020 | Current |
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Pankaj Marwaha | Director | 26-Sep-1988 | Current |
| Manjula Sharma | Director | 24-Jul-1996 | Current |
| Satya Shrivastava | Director | 18-Aug-2014 | Current |
| Ikshit Sharma | Director | 21-Nov-2019 | Current |
Financial Performance and Corporate Structure Insights of Aimil Pharmaceuticals(India).
Aimil Pharmaceuticals(India) Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 7.39% increase. The company also saw a substantial improvement in profitability, with a 41.07% increase in profit. The company's net worth Soared by an impressive increase of 11.95%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Aimil Pharmaceuticals(India)?
In 2022, Aimil Pharmaceuticals(India) had a promoter holding of 96.44% and a public holding of 3.57%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Aimil India Research FoundationActive 6 years 9 monthsKanwal Sharma and Manjula Sharma are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Tata Capital Financial Services Limited Creation Date: 08 Sep 2023 | ₹1.75 Cr | Open |
Others Creation Date: 29 Oct 2021 | ₹13.75 Cr | Open |
Others Creation Date: 08 Oct 2021 | ₹3.48 M | Open |
How Many Employees Work at Aimil Pharmaceuticals(India)?
Aimil Pharmaceuticals(India) has a workforce of 209 employees as of Sep 28, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Aimil Pharmaceuticals(India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aimil Pharmaceuticals(India)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
